FOXP3 and neoplasm: Indeed, TNFα‐CSG therapy increased the abundance of cytotoxic T cells but not immune‐suppressing regulatory (CD4+ CD25+ FOXP3+) T cells in the syngeneic 4T1 tumour model (Fig 7D; gating strategies in Appendix Fig S3D).